WallStSmart

The Ensign Group Inc (ENSG)vsP3 Health Partners Inc (PIII)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

The Ensign Group Inc generates 250% more annual revenue ($5.06B vs $1.44B). ENSG leads profitability with a 6.8% profit margin vs -9.1%. ENSG earns a higher WallStSmart Score of 57/100 (C).

ENSG

Buy

57

out of 100

Grade: C

Growth: 8.0Profit: 6.0Value: 8.0Quality: 5.8
Piotroski: 5/9Altman Z: 2.34

PIII

Avoid

32

out of 100

Grade: F

Growth: 3.7Profit: 2.0Value: 5.0Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

ENSGFair Value (-0.3%)

Margin of Safety

-0.3%

Fair Value

$211.28

Current Price

$203.89

$7.39 premium

UndervaluedFair: $211.28Overvalued

Intrinsic value data unavailable for PIII.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

ENSG1 strengths · Avg: 8.0/10
Revenue GrowthGrowth
20.2%8/10

Revenue surging 20.2% year-over-year

PIII0 strengths · Avg: 0/10

No standout strengths identified

Areas to Watch

ENSG3 concerns · Avg: 3.7/10
PEG RatioValuation
1.784/10

Expensive relative to growth rate

P/E RatioValuation
35.0x4/10

Premium valuation, high expectations priced in

Profit MarginProfitability
6.8%3/10

6.8% margin — thin

PIII4 concerns · Avg: 2.8/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$615.53M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-2.0%2/10

ROE of -2.0% — below average capital efficiency

Revenue GrowthGrowth
-4.7%2/10

Revenue declined 4.7%

Comparative Analysis Report

WallStSmart Research

Bull Case : ENSG

The strongest argument for ENSG centers on Revenue Growth. Revenue growth of 20.2% demonstrates continued momentum.

Bull Case : PIII

PIII has a balanced fundamental profile.

Bear Case : ENSG

The primary concerns for ENSG are PEG Ratio, P/E Ratio, Profit Margin.

Bear Case : PIII

The primary concerns for PIII are EPS Growth, Market Cap, Return on Equity.

Key Dynamics to Monitor

ENSG profiles as a growth stock while PIII is a turnaround play — different risk/reward profiles.

PIII carries more volatility with a beta of 0.85 — expect wider price swings.

ENSG is growing revenue faster at 20.2% — sustainability is the question.

ENSG generates stronger free cash flow (133M), providing more financial flexibility.

Bottom Line

ENSG scores higher overall (57/100 vs 32/100) and 20.2% revenue growth. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

The Ensign Group Inc

HEALTHCARE · MEDICAL CARE FACILITIES · USA

The Ensign Group, Inc. provides health care services in the post-acute care continuum and other ancillary businesses. The company is headquartered in San Juan Capistrano, California.

P3 Health Partners Inc

HEALTHCARE · MEDICAL CARE FACILITIES · USA

P3 Health Partners Inc (PIII) is an innovative healthcare organization committed to enhancing care quality and reducing costs through a robust data-driven strategy. By leveraging advanced analytics and telehealth technologies, P3 prioritizes personalized care for underserved populations while fostering an extensive network of primary care providers and specialists. As a leader in value-based care models, the company strategically collaborates with community partners to meet the rising demand for efficient healthcare solutions. With a steadfast dedication to deliver high-quality and cost-effective care, PIII is well-positioned to navigate and thrive in the evolving healthcare landscape.

Want to dig deeper into these stocks?